INS and obesity disorder: Hence, the higher VAT isoleucine consumption observed in individuals with obesity and pre-diabetes could be a compensatory mechanism to retrain the molecular substrates as an indirect sign of inadequate insulin-mediated gluconeogenesis suppression and IR [5,25].